These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3110956)

  • 1. Gold induced thrombocytopenia: 12 cases and a review of the literature.
    Adachi JD; Bensen WG; Kassam Y; Powers PJ; Bianchi FA; Cividino A; Kean WF; Rooney PJ; Craig GL; Buchanan WW
    Semin Arthritis Rheum; 1987 May; 16(4):287-93. PubMed ID: 3110956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold-induced thrombocytopenia: detection of anti-platelet antibody.
    Armstrong RD; Faith A; Panayi GS; Batchelor JR
    Clin Rheumatol; 1983 Jun; 2(2):183-8. PubMed ID: 6432403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold induced thrombocytopenia: platelet associated IgG and HLA typing in three patients.
    Adachi JD; Bensen WG; Singal DP; Powers PJ
    J Rheumatol; 1984 Jun; 11(3):355-7. PubMed ID: 6610758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA typing, platelet associated immunoglobulins and anticardiolipin antibody.
    Salvarani C; Macchioni P; Ross F; Baricchi R; Filippi G; Iori I; Massai G; Monti M
    J Rheumatol; 1986 Oct; 13(5):988-90. PubMed ID: 3102728
    [No Abstract]   [Full Text] [Related]  

  • 5. Chrysotherapy and thrombocytopenia.
    Madhok R; Pullar T; Capell HA; Dawood F; Sturrock RD; Dick HM
    Ann Rheum Dis; 1985 Sep; 44(9):589-91. PubMed ID: 3929704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia associated with gold therapy. Observations on the mechanism of platelet destruction.
    Levin HA; McMillan R; Tavassoli M; Longmire RL; Yelenosky R; Sacks PV
    Am J Med; 1975 Aug; 59(2):274-80. PubMed ID: 808125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between DR3 and thrombocytopenia due to gold or tiopronin. Case reports and review of the literature.
    Ferraccioli GF; Cavalieri F; Mercadanti M; Salaffi F; Ambanelli U; Savi M
    Clin Exp Rheumatol; 1985; 3(4):341-3. PubMed ID: 3910323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR; Ström H; Bjelle A; Möller E
    Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA DR antigens and gold toxicity.
    Gran JT; Husby G; Thorsby E
    Ann Rheum Dis; 1983 Feb; 42(1):63-6. PubMed ID: 6402993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR antigens in gold-induced neutropenia.
    Aaron S; Davis P; Bertouch J
    Arthritis Rheum; 1986 Dec; 29(12):1515-7. PubMed ID: 3099800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
    Bliddal H; Eiberg B; Helin P; Svejgaard A
    Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and the response to gold therapy in rheumatoid arthritis.
    Carette S; Lang JY; Mathieu JP; Roy R; Morissette J
    Arthritis Rheum; 1987 Feb; 30(2):233. PubMed ID: 3103634
    [No Abstract]   [Full Text] [Related]  

  • 16. Gold-induced immune thrombocytopenia in the dog.
    Bloom JC; Blackmer SA; Bugelski PJ; Sowinski JM; Saunders LZ
    Vet Pathol; 1985 Sep; 22(5):492-9. PubMed ID: 3931338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease?
    von dem Borne AE; Pegels JG; van der Stadt RJ; van der Plas-van Dalen CM; Helmerhorst FM
    Br J Haematol; 1986 Jul; 63(3):509-16. PubMed ID: 3089270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold-induced thrombocytopenia: response to vincristine?
    Ball GV
    Arthritis Rheum; 1977; 20(6):1288-9. PubMed ID: 409415
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA DR antigens and disease expression in rheumatoid arthritis.
    Griffin AJ; Wooley P; Panayi GS; Batchelor JR
    Ann Rheum Dis; 1984 Apr; 43(2):218-21. PubMed ID: 6424587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the clinical and therapeutic aspects of gold induced thrombocytopenia.
    Barton JJ; Burke JP; Casey EB; McCann SR
    Ir Med J; 1985 Jun; 78(6):167-9. PubMed ID: 3924856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.